Baltimore, MD, United States of America

Alan W Partin


Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 236(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Alan W Partin: Innovator in Prostate Cancer Research

Introduction

Alan W Partin is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to the field of prostate cancer research. With a total of 6 patents, Partin has developed innovative methods and markers that aid in the diagnosis and treatment of malignancies.

Latest Patents

Among his latest patents, Partin has introduced nuclear matrix proteins (NMP), which are characterized by a defined expression in tissue. These NMPs serve as useful markers for diagnosing and monitoring the stage of malignancy in cells, as well as treating cell proliferative disorders associated with these proteins. Additionally, he has developed a method for predicting prostate cancer progression by analyzing selected biomarkers. This method evaluates cells from patients at risk for recurrence of prostate cancer following surgery. It utilizes specific Markovian nuclear texture factors, either alone or in combination with other biomarkers, to determine the likelihood of cancer progression. Furthermore, Partin's invention includes a neural network that analyzes and interprets cell morphology data, trained with sets of cell data from known progressors and non-progressors.

Career Highlights

Partin has had a distinguished career, working at esteemed institutions such as The Johns Hopkins University and the University of Tulsa. His research has significantly advanced the understanding of prostate cancer and its progression.

Collaborations

Throughout his career, Partin has collaborated with notable colleagues, including Donald S Coffey and Robert H Getzenberg. Their combined efforts have contributed to the development of innovative solutions in cancer research.

Conclusion

Alan W Partin's work in the field of prostate cancer research exemplifies the impact of innovation in medicine. His patents and research continue to pave the way for advancements in diagnosis and treatment, ultimately benefiting patients at risk for prostate cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…